Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 530.e1-530.e11

  Tsao, Nai Wen ^a   Shih, Chun Ming ^a,b   Yeh, Jong Shiuan ^c   Kao, Yung Ta ^a   Hsieh, Ming Hsiung ^c   Ou, Keng Liang ^c   Chen, Jaw Wen ^d   Shyu, Kou Gi ^e   Weng, Zen Chung ^a   Chang, Nen Chung ^a,b   Lin, Feng Yen ^a,b,c   Huang, Chun Yao ^a,b,c,e  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Extracorporeal membrane oxygenation; Percutaneous coronary intervention

Indexed keywords

DOPAMINE;

ACUTE HEART INFARCTION; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; COUNTERPULSATION; EXTRACORPOREAL OXYGENATION; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TAIWAN; UNIVERSITY HOSPITAL;

EID: 84867332106     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.02.012     Document Type: Article

References (48)

1. Goldberg R.J., Gore J.M., Alpert J.S., et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991, 325:1117-1122.
2. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999, 341:625-634.
3. Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005, 294:448-454.
4. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001, 285:190-192.
5. Berger P.B., Holmes D.R., Stebbins A.L., et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 1997, 96:122-127.
6. Antoniucci D., Valenti R., Santoro G.M., et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998, 31:294-300.
7. Perez-Castellano N., Garcia E., Serrano J.A., et al. Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 1999, 83:989-993.
8. Webb J.G. Interventional management of cardiogenic shock. Can J Cardiol 1998, 14:233-244.
9. Hochman J.S., Boland J., Sleeper L.A., et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation 1995, 91:873-881.
10. Braun K., Kuhl P., Bernd M., et al. Stability of several LHRH antagonists against proteolytic enzymes and identification of degradation products by mass spectrometry. Pharmazie 2001, 56:45-49.
11. McLaughlin M.A. The aging heart. State-of-the-art prevention and management of cardiac disease. Geriatrics 2001, 56:45-49. [quiz 50].
12. Yip H.K., Wu C.J., Chang H.W., et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001, 87:1184-1188. A4.
13. Sheu J.J., Tsai T.H., Lee F.Y., et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010, 38:1810-1817.
14. Wu M.Y., Tsai F.C. Extracorporeal life support in resuscitation for acute myocardial infarction with cardiogenic shock. Chang Gung Med J 2006, 29:207-211.
15. Hochman J.S., Sleeper L.A., Godfrey E., et al. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J 1999, 137:313-321.
16. Goldberg R.J., Gore J.M., Thompson C.A., et al. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J 2001, 141:65-72.
17. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 102:2031-2037.
18. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835-842.
19. Nashef S.A., Roques F., Michel P., et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13.
20. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
21. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005, 1:219-227.
22. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006, 355:2308-2320.
23. Chen J.S., Ko W.J., Yu H.Y., et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006, 34:950-957.
24. Chen Y.S., Lin J.W., Yu H.Y., et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008, 372:554-561.
25. Barron H.V., Every N.R., Parsons L.S., et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001, 141:933-939.
26. Sjauw K.D., Engstrom A.E., Vis M.M., et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J 2009, 30:459-468.
27. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003, 24:28-66.
28. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110:e82-e292.
29. Cheng J.M., den Uil C.A., Hoeks S.E., et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009, 30:2102-2108.
30. Doll N., Kiaii B., Borger M., et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004, 77:151-157. [discussion 7].
31. Lietz K., Miller L.W. Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009, 24:246-251.
32. Rajdev S., Irani A., Sharma S., et al. Clinical utility of TandemHeart for high-risk tandem procedures: percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol 2007, 19:E346-E349.
33. Vranckx P., Foley D.P., de Feijter P.J., et al. Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent 2003, 5:35-39.
34. Siegenthaler M.P., Brehm K., Strecker T., et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 2004, 127:812-822.
35. Meyns B., Dens J., Sergeant P., et al. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003, 51:312-317.
36. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
37. Mehta S.R., Cannon C.P., Fox K.A., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005, 293:2908-2917.
38. Bavry A.A., Kumbhani D.J., Rassi A.N., et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006, 48:1319-1325.
39. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000, 283:2941-2947.
40. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329.
41. Mehta S.R., Granger C.B., Boden W.E., et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009, 360:2165-2175.
42. Holmes D.R., Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999, 100:2067-2073.
43. Jacobs A.K., French J.K., Col J., et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?. J Am Coll Cardiol 2000, 36:1091-1096.
44. Dhurandhar R.W., MacMillan R.L., Brown K.W. Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol 1971, 27:347-351.
45. Pantridge J.F., Geddes J.S. A mobile intensive-care unit in the management of myocardial infarction. Lancet 1967, 2:271-273.
46. Cohen M.I., Gaynor J.W., Ramesh V., et al. Extracorporeal membrane oxygenation for patients with refractory ventricular arrhythmias. J Thorac Cardiovasc Surg 1999, 118:961-963.
47. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006, 47:2180-2186.
48. Reynolds H.R., Hochman J.S. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008, 117:686-697.